BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 29751783)

  • 1. Antiproliferative and apoptotic effect of LY2090314, a GSK-3 inhibitor, in neuroblastoma in vitro.
    Kunnimalaiyaan S; Schwartz VK; Jackson IA; Clark Gamblin T; Kunnimalaiyaan M
    BMC Cancer; 2018 May; 18(1):560. PubMed ID: 29751783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activating the Wnt/β-Catenin Pathway for the Treatment of Melanoma--Application of LY2090314, a Novel Selective Inhibitor of Glycogen Synthase Kinase-3.
    Atkinson JM; Rank KB; Zeng Y; Capen A; Yadav V; Manro JR; Engler TA; Chedid M
    PLoS One; 2015; 10(4):e0125028. PubMed ID: 25915038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific glycogen synthase kinase-3 inhibition reduces neuroendocrine markers and suppresses neuroblastoma cell growth.
    Carter YM; Kunnimalaiyaan S; Chen H; Gamblin TC; Kunnimalaiyaan M
    Cancer Biol Ther; 2014 May; 15(5):510-5. PubMed ID: 24521712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic efficacy of inhibiting MYCN and mTOR signaling against neuroblastoma.
    Kling MJ; Griggs CN; McIntyre EM; Alexander G; Ray S; Challagundla KB; Joshi SS; Coulter DW; Chaturvedi NK
    BMC Cancer; 2021 Sep; 21(1):1061. PubMed ID: 34565342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tideglusib attenuates growth of neuroblastoma cancer stem/progenitor cells in vitro and in vivo by specifically targeting GSK-3β.
    Bahmad HF; Chalhoub RM; Harati H; Bou-Gharios J; Assi S; Ballout F; Monzer A; Msheik H; Araji T; Elajami MK; Ghanem P; Chamaa F; Kadara H; Abou-Antoun T; Daoud G; Fares Y; Abou-Kheir W
    Pharmacol Rep; 2021 Feb; 73(1):211-226. PubMed ID: 33030673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xanthohumol increases death receptor 5 expression and enhances apoptosis with the TNF-related apoptosis-inducing ligand in neuroblastoma cell lines.
    Engelsgjerd S; Kunnimalaiyaan S; Kandil E; Gamblin TC; Kunnimalaiyaan M
    PLoS One; 2019; 14(3):e0213776. PubMed ID: 30870485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An open-label phase 2 study of glycogen synthase kinase-3 inhibitor LY2090314 in patients with acute leukemia.
    Rizzieri DA; Cooley S; Odenike O; Moonan L; Chow KH; Jackson K; Wang X; Brail L; Borthakur G
    Leuk Lymphoma; 2016 Aug; 57(8):1800-6. PubMed ID: 26735141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The MDM2 inhibitor CGM097 combined with the BET inhibitor OTX015 induces cell death and inhibits tumor growth in models of neuroblastoma.
    Maser T; Zagorski J; Kelly S; Ostrander A; Goodyke A; Nagulapally A; Bond J; Park Y; Saulnier Sholler G
    Cancer Med; 2020 Nov; 9(21):8144-8158. PubMed ID: 33034426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ursolic acid from Oldenlandia diffusa induces apoptosis via activation of caspases and phosphorylation of glycogen synthase kinase 3 beta in SK-OV-3 ovarian cancer cells.
    Song YH; Jeong SJ; Kwon HY; Kim B; Kim SH; Yoo DY
    Biol Pharm Bull; 2012; 35(7):1022-8. PubMed ID: 22791147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo inhibition of neuroblastoma tumor cell growth by AKT inhibitor perifosine.
    Li Z; Tan F; Liewehr DJ; Steinberg SM; Thiele CJ
    J Natl Cancer Inst; 2010 Jun; 102(11):758-70. PubMed ID: 20463309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetazolamide potentiates the anti-tumor potential of HDACi, MS-275, in neuroblastoma.
    Bayat Mokhtari R; Baluch N; Ka Hon Tsui M; Kumar S; S Homayouni T; Aitken K; Das B; Baruchel S; Yeger H
    BMC Cancer; 2017 Feb; 17(1):156. PubMed ID: 28235409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of neuroblastoma cell growth inhibition by CARP-1 functional mimetics.
    Muthu M; Cheriyan VT; Munie S; Levi E; Frank J; Ashour AE; Singh M; Rishi AK
    PLoS One; 2014; 9(7):e102567. PubMed ID: 25033461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PI3K Inhibitor Combined With Chemotherapy Can Enhance the Apoptosis of Neuroblastoma Cells In Vitro and In Vivo.
    Geng X; Xie L; Xing H
    Technol Cancer Res Treat; 2016 Oct; 15(5):716-22. PubMed ID: 26224681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzymatic Spermine Metabolites Induce Apoptosis Associated with Increase of p53, caspase-3 and miR-34a in Both Neuroblastoma Cells, SJNKP and the N-Myc-Amplified Form IMR5.
    Kanamori Y; Finotti A; Di Magno L; Canettieri G; Tahara T; Timeus F; Greco A; Tirassa P; Gasparello J; Fino P; Di Liegro CM; Proia P; Schiera G; Di Liegro I; Gambari R; Agostinelli E
    Cells; 2021 Jul; 10(8):. PubMed ID: 34440719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-149 is associated with clinical outcome in human neuroblastoma and modulates cancer cell proliferation through Rap1 independent of MYCN amplification.
    Xu Y; Chen X; Lin L; Chen H; Yu S; Li D
    Biochimie; 2017 Aug; 139():1-8. PubMed ID: 28456710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GSK-3β inhibition promotes cell death, apoptosis, and in vivo tumor growth delay in neuroblastoma Neuro-2A cell line.
    Dickey A; Schleicher S; Leahy K; Hu R; Hallahan D; Thotala DK
    J Neurooncol; 2011 Aug; 104(1):145-53. PubMed ID: 21161565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UCN-01 alters phosphorylation of Akt and GSK3beta and induces apoptosis in six independent human neuroblastoma cell lines.
    Shankar SL; Krupski M; Parashar B; Okwuaka C; O'Guin K; Mani S; Shafit-Zagardo B
    J Neurochem; 2004 Aug; 90(3):702-11. PubMed ID: 15255949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and biological evaluation of N-alkyl or aryl substituted isoindigo derivatives as potential dual cyclin-dependent kinase 2 (CDK2)/glycogen synthase kinase 3β (GSK-3β) phosphorylation inhibitors.
    Zhao P; Li Y; Gao G; Wang S; Yan Y; Zhan X; Liu Z; Mao Z; Chen S; Wang L
    Eur J Med Chem; 2014 Oct; 86():165-74. PubMed ID: 25151579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone-lysine methyltransferase EHMT2 is involved in proliferation, apoptosis, cell invasion, and DNA methylation of human neuroblastoma cells.
    Lu Z; Tian Y; Salwen HR; Chlenski A; Godley LA; Raj JU; Yang Q
    Anticancer Drugs; 2013 Jun; 24(5):484-93. PubMed ID: 23466651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-Deoxyglucose treatment complements the cisplatin- or BH3-only mimetic-induced suppression of neuroblastoma cell growth.
    Chuang JH; Chou MH; Tai MH; Lin TK; Liou CW; Chen T; Hsu WM; Wang PW
    Int J Biochem Cell Biol; 2013 May; 45(5):944-51. PubMed ID: 23395630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.